Meeting
2017 ASCO Annual Meeting
Predicting response to radical (chemo)radiotherapy (R-CRT) with circulating HPV DNA and tumor DNA (ctDNA) analysis in locally-advanced head and neck squamous cell carcinoma (LAHNC).
Authors
Shreerang Bhide
The Royal Marsden Hospital, Sutton, United Kingdom
Shreerang Bhide , Jen Lee , Isaac Garcia-Murillas , Ros Cutts , Tara Hurley , Lorna Grove , Christopher Nutting , Kate Newbold , Nicholas C. Turner , Kevin Harrington
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6043)
DOI
10.1200/JCO.2017.35.15_suppl.6043
Abstract #
6043
Poster Bd #
31
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
First Author: Enrique Sanz Garcia
Poster
2020 ASCO Virtual Scientific Program
HPV ctDNA analysis in unresectable recurrent/metastatic oropharyngeal cancer.
First Author: Catherine T Haring
Poster
2020 ASCO Virtual Scientific Program
Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer.
First Author: Ralph Zinner
Poster
2019 ASCO Annual Meeting
Randomized phase II study with or without induction chemotherapy combined with accelerated high dose radiotherapy and cetuximab in locally advanced unresectable HPV positive squamous cell carcinoma of the head and neck.
First Author: Signe Friesland